Literature DB >> 22013220

Inactivation and survival of hepatitis C virus on inanimate surfaces.

Juliane Doerrbecker1, Martina Friesland, Sandra Ciesek, Thomas J Erichsen, Pedro Mateu-Gelabert, Jörg Steinmann, Jochen Steinmann, Thomas Pietschmann, Eike Steinmann.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) cross-contamination from inanimate surfaces or objects has been implicated in transmission of HCV in health-care settings and among injection drug users. We established HCV-based carrier and drug transmission assays that simulate practical conditions to study inactivation and survival of HCV on inanimate surfaces.
METHODS: Studies were performed with authentic cell culture derived viruses. HCV was dried on steel discs and biocides were tested for their virucidal efficacy against HCV. Infectivity was determined by a limiting dilution assay. HCV stability was analyzed in a carrier assay for several days or in a drug transmission assay using a spoon as cooker.
RESULTS: HCV can be dried and recovered efficiently in the carrier assay. The most effective alcohol to inactivate the virus was 1-propanol, and commercially available disinfectants reduced infectivity of HCV to undetectable levels. Viral infectivity on inanimate surfaces was detectable in the presence of serum for up to 5 days, and temperatures of about 65-70°C were required to eliminate infectivity in the drug transmission assay.
CONCLUSIONS: These findings are important for assessment of HCV transmission risks and should facilitate the definition of stringent public health interventions to prevent HCV infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22013220      PMCID: PMC3247810          DOI: 10.1093/infdis/jir535

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  40 in total

1.  A disc-based quantitative carrier test method to assess the virucidal activity of chemical germicides.

Authors:  Syed A Sattar; V Susan Springthorpe; Olusola Adegbunrin; A Abu Zafer; Maria Busa
Journal:  J Virol Methods       Date:  2003-09       Impact factor: 2.014

2.  The beginning of a new era in understanding hepatitis C virus prevention.

Authors:  Josiah D Rich; Lynn E Taylor
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

Review 3.  Management of occupational exposures to blood-borne viruses.

Authors:  J L Gerberding
Journal:  N Engl J Med       Date:  1995-02-16       Impact factor: 91.245

4.  Survival of hepatitis B virus after drying and storage for one week.

Authors:  W W Bond; M S Favero; N J Petersen; C R Gravelle; J W Ebert; J E Maynard
Journal:  Lancet       Date:  1981-03-07       Impact factor: 79.321

Review 5.  Risk of occupational infection with blood-borne pathogens in operating and delivery room settings.

Authors:  L J Short; D M Bell
Journal:  Am J Infect Control       Date:  1993-12       Impact factor: 2.918

6.  Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees.

Authors:  Michelina Nascimbeni; Eishiro Mizukoshi; Markus Bosmann; Marian E Major; Kathleen Mihalik; Charles M Rice; Stephen M Feinstone; Barbara Rehermann
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

7.  Hepatitis C virus seroconversion among young injection drug users: relationships and risks.

Authors:  Judith A Hahn; Kimberly Page-Shafer; Paula J Lum; Philippe Bourgois; Ellen Stein; Jennifer L Evans; Michael P Busch; Leslie H Tobler; Bruce Phelps; Andrew R Moss
Journal:  J Infect Dis       Date:  2002-11-04       Impact factor: 5.226

8.  Impact of specimen handling and storage on detection of hepatitis C virus RNA.

Authors:  M P Busch; J C Wilber; P Johnson; L Tobler; C S Evans
Journal:  Transfusion       Date:  1992-06       Impact factor: 3.157

Review 9.  Viral hepatitis transmission in ambulatory health care settings.

Authors:  I T Williams; J F Perz; B P Bell
Journal:  Clin Infect Dis       Date:  2004-05-12       Impact factor: 9.079

10.  A large nosocomial outbreak of hepatitis C and hepatitis B among patients receiving pain remediation treatments.

Authors:  R Dawn Comstock; Sue Mallonee; Jan L Fox; Ronald L Moolenaar; Tara M Vogt; Joseph F Perz; Beth P Bell; James M Crutcher
Journal:  Infect Control Hosp Epidemiol       Date:  2004-07       Impact factor: 3.254

View more
  42 in total

1.  Development, validation, and potential applications of the hepatitis C virus injection-risk knowledge scale (HCV-IRKS) among young opioid users in New York City.

Authors:  Kelly Quinn; Chunki Fong; Honoria Guarino; Pedro Mateu-Gelabert
Journal:  Drug Alcohol Depend       Date:  2018-11-28       Impact factor: 4.492

2.  Patterns of drug use, risky behavior, and health status among persons who inject drugs living in San Diego, California: a latent class analysis.

Authors:  Alexis M Roth; Richard A Armenta; Karla D Wagner; Scott C Roesch; Ricky N Bluthenthal; Jazmine Cuevas-Mota; Richard S Garfein
Journal:  Subst Use Misuse       Date:  2014-10-14       Impact factor: 2.164

3.  Factors in the Selection of Surface Disinfectants for Use in a Laboratory Animal Setting.

Authors:  Michael V Campagna; Emmanuelle Faure-Kumar; Janet A Treger; Jesse D Cushman; Tristan R Grogan; Noriyuki Kasahara; Gregory W Lawson
Journal:  J Am Assoc Lab Anim Sci       Date:  2016-03       Impact factor: 1.232

Review 4.  Transmission of hepatitis C virus infection through tattooing and piercing: a critical review.

Authors:  Rania A Tohme; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2012-01-30       Impact factor: 9.079

5.  Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention.

Authors:  Kimberly Page; Meghan D Morris; Judith A Hahn; Lisa Maher; Maria Prins
Journal:  Clin Infect Dis       Date:  2013-08       Impact factor: 9.079

6.  Opioid Use Trajectories, Injection Drug Use, and Hepatitis C Virus Risk Among Young Adult Immigrants from the Former Soviet Union Living in New York City.

Authors:  Honoria Guarino; Lisa A Marsch; Sherry Deren; Shulamith L A Straussner; Anastasia Teper
Journal:  J Addict Dis       Date:  2015

7.  Mechanisms of methods for hepatitis C virus inactivation.

Authors:  Stephanie Pfaender; Janine Brinkmann; Daniel Todt; Nina Riebesehl; Joerg Steinmann; Jochen Steinmann; Thomas Pietschmann; Eike Steinmann
Journal:  Appl Environ Microbiol       Date:  2014-12-19       Impact factor: 4.792

8.  Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study.

Authors:  Matthew J Akiyama; Charles M Cleland; John A Lizcano; Peter Cherutich; Ann E Kurth
Journal:  Lancet Infect Dis       Date:  2019-09-17       Impact factor: 25.071

Review 9.  Epidemiology of hepatitis C in Croatia in the European context.

Authors:  Tatjana Vilibic-Cavlek; Jasmina Kucinar; Bernard Kaic; Maja Vilibic; Nenad Pandak; Ljubo Barbic; Vladimir Stevanovic; Jasmina Vranes
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

10.  Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics.

Authors:  Jon E Zibbell; Rachel Hart-Malloy; John Barry; Lillian Fan; Colleen Flanigan
Journal:  Am J Public Health       Date:  2014-09-11       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.